EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nano-Radiopharmaceuticals in Colon Cancer: Current Applications, Challenges, and Future Directions

Ajnas Alkatheeri iD, Suliman Salih, Noon Kamil iD, Sara Alnuaimi iD, Memona Abuzar, Shahd Shehadeh Abdelrahman iD

Pharmaceuticals · 14.02.2025 · 18 (2) · 257

DOI: 10.3390/ph18020257 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 14.02.2025. Verfasst von Ajnas Alkatheeri und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiography and Medical Imaging, Fatima College of Health Sciences, Abu Dhabi 3798, United Arab Emirates. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colon cancer remains a significant global health challenge; however, the treatment outcome for colon patients can be improved through early detection and effective treatment. Nano-radiopharmaceuticals, combining nanotechnology with radiopharmaceuticals, are emerging as a revolutionary approach in both colon cancer diagnostic imaging and therapy, playing a significant role in the management of colon cancer patients. This review examines the use of nano-radiopharmaceuticals in the diagnosis and treatment of colon cancer, highlighting current applications, challenges, and future directions. Nanocarriers of radionuclides have shown potential in improving cancer treatment, including liposomes, microparticles, nanoparticles, micelles, dendrimers, and hydrogels, which are approved by the FDA. These nanocarriers can deliver targeted drugs into malignant cells without affecting normal cells, reducing side effects. Antibody-guided systemic radionuclide-targeted therapy has shown potential for treating cancer. Novel cancer nanomedicines, like Hensify and 32P BioSilicon, are under clinical development for targeted radiation delivery in percutaneous intratumoral injections. Although using nano-radiopharmaceuticals is a superior technique for diagnosing and treating colon cancer, there are limitations and challenges, such as the unintentional accumulation of nanoparticles in healthy tissues, which leads to toxicity due to biodistribution issues, as well as high manufacturing costs that limit their availability for patients. However, the future direction is moving toward providing more precise radiopharmaceuticals, which is crucial for enhancing the diagnosis and treatment of colon cancer and reducing production costs.

Schlagwörter

Stichwörter der Autor:innen

colorectal cancernano-radiopharmaceuticalsnanoparticlesradiolabeledtheranostics

Autor:innen und Institutionen

  • Department of Radiography and Medical Imaging, Fatima College of Health Sciences, Abu Dhabi 3798, United Arab Emirates.
  • National Cancer Institute, University of Gezira, Wad Madani 2667, Sudan.
  • Department of Pharmacy, Fatima College of Health Sciences, Abu Dhabi 3798, United Arab Emirates.
  • College of Medicine and Health Sciences, Khalifa University, Abu Dhabi 3798, United Arab Emirates.

ORCID-Profile: Ajnas Alkatheeri, Noon Kamil, Sara Alnuaimi, Shahd Shehadeh Abdelrahman

Zitieren

APA

Alkatheeri, A., Salih, S., Kamil, N., Alnuaimi, S., Abuzar, M., & Abdelrahman, S. S. (2025). Nano-Radiopharmaceuticals in Colon Cancer: Current Applications, Challenges, and Future Directions. Pharmaceuticals, 18(2), 257. https://doi.org/10.3390/ph18020257

Vancouver

Alkatheeri A, Salih S, Kamil N, Alnuaimi S, Abuzar M, Abdelrahman SS. Nano-Radiopharmaceuticals in Colon Cancer: Current Applications, Challenges, and Future Directions. Pharmaceuticals. 2025;18(2):257. doi:10.3390/ph18020257

BibTeX
@article{Alkatheeri2025,
  author = {Alkatheeri, Ajnas and Salih, Suliman and Kamil, Noon and Alnuaimi, Sara and Abuzar, Memona and Abdelrahman, Shahd Shehadeh},
  title = {Nano-Radiopharmaceuticals in Colon Cancer: Current Applications, Challenges, and Future Directions},
  journal = {Pharmaceuticals},
  year = {2025},
  volume = {18},
  number = {2},
  pages = {257},
  doi = {10.3390/ph18020257}
}
Kostenlos starten →